Altechromone A Ameliorates Inflammatory Bowel Disease by Inhibiting NF-κB and NLRP3 Pathways
Marine Drugs · 09.09.2024 · 22 (9) · 410
DOI: 10.3390/md22090410 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, online erschienen am 09.09.2024. Verfasst von Lei Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Biology Institute, Qilu University of Technology (Shandong Academy of Sciences), Jinan 250103, China. Hauptthemen laut MEDLINE: Zebrafish, NF-kappa B, Inflammatory Bowel Diseases, NLR Family, Pyrin Domain-Containing 3 Protein. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shandong Provincial Natural Science Foundation, Taishan Scholar Project from Shandong Province.
Abstract (Originalsprache)
Altechromone A, also known as 2,5-dimethyl-7-hydroxychromone, is a hydroxyketone containing one hydroxyl and one ketone group. In this study, we isolated Altechromone A from the marine-derived fungus Penicillium Chrysogenum (XY-14-0-4). Previous reports show that Altechromone A has various activities including tumor suppression, antibacterial, and antiviral activities. However, there is no study about its anti-inflammatory activity in inflammatory bowel disease (IBD). Here, we assess the anti-inflammatory activity, especially in IBD, and its potential mechanism using the zebrafish model. Our results indicated that Altechromone A has anti-inflammatory activity in a CuSO4-, tail-cutting-, and LPS-induced inflammatory model in zebrafish, respectively. In addition, Altechromone A greatly reduced the number of neutrophils, improved intestinal motility and efflux efficiency, alleviated intestinal damage, and reduced reactive oxygen species production in the TNBS-induced IBD zebrafish model. The transcriptomics sequencing and real-time qPCR indicated that Altechromone A inhibited the expression of pro-inflammatory genes including TNF-α, NF-κB, IL-1, IL-1β, IL-6, and NLRP3. Therefore, these data indicate that Altechromone A exhibits therapeutic effects in IBD by inhibiting the inflammatory response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biology Institute, Qilu University of Technology (Shandong Academy of Sciences), Jinan 250103, China.
- Engineering Research Center of Zebrafish Models for Human Diseases and Drug Screening of Shandong Province, Jinan 250103, China.
- Medical Decision and Economic Group, Department of Pharmacy, Ren Ji Hospital, South Campus, School of Medicine, Shanghai Jiaotong University, Shanghai 200030, China.
ORCID-Profile: Lei Li, Houwen Lin, Xiaobin Li
Förderung
- National Natural Science Foundation of China
- Shandong Provincial Natural Science Foundation
- Taishan Scholar Project from Shandong Province
- Taishan Scholars Program
- Jinan Talent Project for Universities
- Shandong High-End Foreign Experts Recruitment Program
Zitieren
APA
Li, L., Huang, J., Feng, L., Xu, L., Lin, H., Liu, K., Li, X., & Wang, R. (2024). Altechromone A Ameliorates Inflammatory Bowel Disease by Inhibiting NF-κB and NLRP3 Pathways. Marine Drugs, 22(9), 410. https://doi.org/10.3390/md22090410
Vancouver
Li L, Huang J, Feng L, Xu L, Lin H, Liu K, et al. Altechromone A Ameliorates Inflammatory Bowel Disease by Inhibiting NF-κB and NLRP3 Pathways. Marine Drugs. 2024;22(9):410. doi:10.3390/md22090410
BibTeX
@article{Li2024,
author = {Li, Lei and Huang, Jing and Feng, Lixin and Xu, Liyan and Lin, Houwen and Liu, Kechun and Li, Xiaobin and Wang, Rongchun},
title = {Altechromone A Ameliorates Inflammatory Bowel Disease by Inhibiting NF-κB and NLRP3 Pathways},
journal = {Marine Drugs},
year = {2024},
volume = {22},
number = {9},
pages = {410},
doi = {10.3390/md22090410}
}
EUVIMED